Nanosonics
Private Company
Funding information not available
Overview
Nanosonics is a commercial-stage medical device company focused on automated disinfection systems for ultrasound probes and endoscopes. Its core technology, the trophon® device, utilizes a hydrogen peroxide mist to provide high-level disinfection, addressing critical infection control gaps in hospitals. The company has established a significant global footprint, with over 35,000 units deployed protecting millions of patients, and is expanding its platform into the complex endoscope reprocessing market. It operates as a revenue-generating entity with a direct sales and support model.
Technology Platform
Proprietary automated high-level disinfection (HLD) platform using sonically generated hydrogen peroxide (H₂O₂) mist. The technology is designed for reprocessing sensitive medical equipment like ultrasound probes and endoscopes, featuring automation for standardization, digital traceability, and a closed-system that breaks H₂O₂ down into water and oxygen.
Opportunities
Risk Factors
Competitive Landscape
In ultrasound probe disinfection, Nanosonics' trophon system is a market leader, competing against manual chemical baths, other automated chemical disinfection systems, and ultraviolet light devices. For endoscope reprocessing, the competitive landscape is dominated by manual cleaning protocols and automated endoscope reprocessors (AERs) using various chemistries; entering this space will pit Nanosonics against established players like Olympus, Cantel Medical, and STERIS.